SCHEMBL601212

SCHEMBL601212

NCCNCCN1CCN(CCN)CC1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.91
ALOX15 P16050 2/20 0.62
CA12 O43570 3/20 0.48
CA6 P23280 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48
CA14 Q9ULX7 3/20 0.48
CA5B Q9Y2D0 3/20 0.48
MEN1 O00255 1/20 0.48
RECQL P46063 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
CA2 P00918 2/20 0.46
CA3 P07451 2/20 0.46
CA4 P22748 2/20 0.46
CA5A P35218 2/20 0.46
CA1 P00915 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22025304 0.98 ACE2 (0.86) ACE2ALOX15CA12CA6CA7
SCHEMBL30066712 0.98 ACE2 (0.86) ACE2ALOX15CA12CA6CA7
SCHEMBL12921297 0.95 ACE2 (1.00) ACE2ALOX15CA12CA6CA7
SCHEMBL30066688 0.95 ACE2 (0.81) ACE2ALOX15CA12CA6CA7
SCHEMBL1690928 0.95
SCHEMBL2570372 0.93 ACE2 (0.95) ACE2ALOX15CA12CA6CA7
SCHEMBL3975414 0.88 ACE2 (0.70) ACE2ALOX15CA12CA6CA7
SCHEMBL22416388 0.86 ACE2 (0.83) ACE2ALOX15CA12CA6CA7
SCHEMBL3913565 0.86 ACE2 (0.82) ACE2ALOX15CA12CA6CA7
SCHEMBL16504284 0.85 ACE2 (0.65) ACE2ALOX15ALDH1A1KDM4ESIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354174-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TIBA BIOTECH LLC (US) 2025-11-20 US claimed
US-12410448-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TIBA BIOTECH LLC (US) 2025-09-09 US claimed
WO-2025080555-A1 SUBSTITUTED AMIDINE IONIZABLE LIPID COMPOUNDS, METHODS OF PREPARATION THEREOF, LIPID NANOPARTICLES (LNPS) COMPRISING THE SAME, AND METHODS OF USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2025-04-17 WO claimed
WO-2025072371-A2 HIGHLY ACTIVE MYELOID THERAPY THE GENERAL HOSPITAL CORPORATION (US) 2025-04-03 WO claimed
US-12163046-B2 Water-based coating composition and method for forming multilayer coating film using said composition BASF COATINGS GMBH (DE) 2024-12-10 US claimed
CN-118655750-A Stripping liquid for semiconductor compound photoresist, preparation method and application thereof 浙江奥首材料科技有限公司 2024-09-17 CN claimed
CN-117897152-A Nanoparticle compositions containing sugar-functionalized nucleic acid vectors 蒂巴生物技术有限公司 2024-04-16 CN claimed
US-20240093238-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TIBA BIOTECH LLC (US) 2024-03-21 US claimed
US-20240067858-A1 ALIPHATIC EPOXY RESIN CROSSLINKED POLYMERS FOR PRIMARY CEMENTING IN A BOREHOLE SAUDI ARABIAN OIL COMPANY (SA) 2024-02-29 US claimed
CN-114783788-B Carbon fiber electrode for nitrogen-phosphorus in-situ doped supercapacitor and preparation and application thereof 中国科学院宁波材料技术与工程研究所 2024-02-02 CN claimed
WO-2016091546-A1 AQUEOUS POLYURETHANE-POLYUREA DISPERSION AND AQUEOUS BASE PAINT CONTAINING SAID DISPERSION BASF COATINGS GMBH (DE) 2016-06-16 WO claimed
WO-2015067463-A1 CATIONIC ALKYD RESINS ALLNEX AUSTRIA GMBH (AT) 2015-05-14 WO claimed
EP-2871195-A1 Cationic Alkyd Resins ALLNEX AUSTRIA GmbH (AT) 2015-05-13 EP claimed
US-8946282-B2 Indolin-2-one derivatives as protein kinase inhibitors Annji Pharmaceutical Co., Ltd. (TW) 2015-02-03 US claimed
US-8945280-B2 Method to decrease decomposition products in solutions that absorb acidic gases such as carbon dioxide and the like in the presence of oxygen HUNTSMAN PETROCHEMICAL LLC (US) 2015-02-03 US claimed
US-8765008-B2 Hydroxyalkylated polyalkylenepolyamine composition, method for producing same and method for producing polyurethane resin using such hydroxyalkylated polyalkylenepolyamine composition TOSOH CORPORATION (JP) 2014-07-01 US claimed
US-20120252661-A1 HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SUCH HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION TOSOH CORPORATION (JP) 2012-10-04 US claimed
US-20120041088-A1 FOAMING ADDITIVE FOR PRODUCING POLYURETHANE FOAM, AND METHOD FOR PRODUCING RIGID POLYURETHANE FOAM BY USING IT TOSOH CORPORATION (JP) 2012-02-16 US claimed
US-20080004362-A1 Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition TOSOCH CORPORATION (JP) 2008-01-03 US claimed
EP-1813599-A1 HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SUCH HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION Tosoh Corporation (JP) 2007-08-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250354174-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TLR9, TLR3, TSG101 ACE2 2479/4885ALOX15 4133/4885CA12 818/4885
US-20080004362-A1 Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition SRM, HRH3, HNMT ACE2 3914/4885ALOX15 1697/4885CA12 4484/4885
US-20240093238-A1 NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS TLR9, TLR3, TSG101 ACE2 2479/4885ALOX15 4133/4885CA12 818/4885
US-12410448-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TLR9, TLR3, TSG101 ACE2 2479/4885ALOX15 4133/4885CA12 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.